Should translation requirements apply equally in patent law?
A recent High Court judgment in India highlights a potential procedural fairness question in patent examination regarding English translation standards. While patent applicants face rigorous translation requirements under multiple Patent Rules, with severe...
UPC validates second medical use patent in Sanofi v. Amgen antibody therapeutics ruling, finds non-infringement
The Düsseldorf Local Division of the Unified Patent Court (UPC) has handed down a key decision in UPC CFI 505/2024, affirming the validity of a second medical use patent owned by Regeneron and licensed to Sanofi. The case involved alleged infringement by Amgen’s PCSK9...
Certainty for businesses and choice for consumers as UK maintains IP rights regime
No legislative changes mean businesses can continue operating under the existing exhaustion of intellectual property rights regime without any new requirements. The UK+ regime protects creators and innovators while ensuring fair competition in the marketplace and...
Annual Report 2024 of the Boards of Appeal of the European Patent Office
The Annual Report 2024 of the Boards of Appeal of the European Patent Office has been published today. It is available in English, German, and French on the Boards' website. Delivering decisions of the highest quality continued to be a central priority in 2024. As in...
Crystal Crop v. Safex: Delhi High Court on Doctrine of Equivalents and prosecution history estoppel in patent disputes
In Crystal Crop Protection Ltd. v. Safex Chemicals India Ltd. & Ors., CS(COMM) 196/2024, Neutral Citation: 2025:DHC:3382, decided on May 7, 2025 by Hon’ble Mr Justice Amit Bansal of the Delhi High Court, the court refused to grant an interim injunction, holding...
UK IPO campaign highlights dangers of counterfeit vehicle parts
The campaign focuses on the serious risks these goods pose, warning that ‘Fake Always Breaks’ The UK Intellectual Property Office (UKIPO) has launched a new national awareness campaign warning of the dangers of buying counterfeit vehicle parts The ‘Fake Always...
Welcome to Hangzhou! The AIPPI World Congress 2024
AIPPI World Congress 2024 opened its doors in Hangzhou, China, on Saturday, 19 October. All attending were warmly welcomed, and there was general excitement for the next few days of educational sessions, member meetings, and networking. Guoqing ZHANG, Vice Premier of...
Crystalizing plant variety infringement protection in India
On September 20, 2024, the Delhi High Court ruled in Pioneer Overseas Corporation v. M/s Evercrop Agro Science & Star Agrotech Pvt. Ltd. (CS(COMM) 759/2024), a significant case addressing plant variety infringement under the Protection of Plant Varieties and...
German criminal court finds three defendants guilty of fraud for sending misleading invoices to EUIPO customers
In September 2024, the Munich Court (Germany) found three defendants guilty of commercial gang fraud for sending misleading invoices to EUIPO customers. Each defendant was sentenced to one year and 10 months of imprisonment, suspended with a three-year probation...
Pocketpair, I choose you… to sue: an early glimpse into the Nintendo-Pocketpair litigation
Out of the blue on September 19, 2024, video game company Nintendo and The Pokémon Company issued a joint news release via a post on the Nintendo website. The post asserted that Pocketpair infringed certain patents but contained sparse details about the alleged...
Increase in patent fees in Russia
From October 5, 2024, the amount of patent fees collected in Russia has increased in accordance with the relevant draft government resolution. The changes will affect legally significant actions related to such intellectual property items as inventions, utility...
COPA and Unified Patents sign partnership to protect the crypto community from patent trolls
Launch of Blockchain Zone to challenge patents owned by non-practicing entities (NPEs) that could impact the open-source ecosystem NPEs still account for 58% of all [US] patent litigation; partnership aims to deter NPE activity in crypto October 1, 2024 - Today,...
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services Dublin, Ireland, and Montreal, Canada - October 1, 2024 - ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Université de...
Relentless pursuit of victory: BMW Group prevails in Arigna patent litigation saga
BMW Group prevailed in its long-running battle against Arigna Technology Ltd. While Arigna’s efforts spanned years and multiple venues — BMW Group’s multi-faceted legal strategy and refusal to settle ultimately forced Arigna to fold. Pressuring from all sides: BMW...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.